Troutman Pepper advised Innervace on the deal. Innervace, a regenerative medicine company developing the first implantable biofabricated neural pathway to restore brain circuitry, announced its $40...
You must be a Standard 1 Year member to access this content.
Troutman Pepper advised Center for Breakthrough Medicines on the deal. Center for Breakthrough Medicines (CBM) has struck a landmark collaboration agreement with the University of Pennsylvania’s...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented SK Group on the deal while Troutman Pepper Hamilton Sanders advised Center for Breakthrough Medicines. SK Inc. announced its $350 million investment in The...
You must be a Standard 1 Year member to access this content.
